Pharma Pathway

DECEMBER 8, 2022

Hetero Labs Limited-Walk-In Interviews for Production/ Packing/ QC Departments On 10th Dec’ 2022. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 76

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 76

pharmaphorum

APRIL 1, 2022

Congress and the White House to curtail prescription drug prices, many experts continue to point to biosimilars and their promising potential to usher in competition, increase access, and drive down costs for patients—and the U.S. And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko.

Biosimilars 59

Biosimilars Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Pathway

SEPTEMBER 15, 2022

Walk-In Interview for MSAT & Process Engineering-Injectables On 18th Sept’ 2022. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Company Name: Dr. Reddy’s Laboratories. Date : 18th Sept’ 2022. Reddy’s Laboratories Ltd.-Walk-In

Biosimilars 87

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 87

Pharma Pathway

SEPTEMBER 22, 2022

Walk-In Interview for Freshers On 23rd Sept’ 2022. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Job Description.

Documentation 79

Documentation Biosimilars Pharmaceutical Companies Pharmaceutical Companies 79

Pharma Pathway

SEPTEMBER 14, 2022

Walk-In Interviews for Manufacturing On 18th Sept’ 2022. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products.

Biosimilars 77

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 77

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 71

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 71

Pharma Pathway

FEBRUARY 26, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 5th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 85

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 85

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Pathway

FEBRUARY 14, 2023

Hetero Labs Limited-Placement Drive for Freshers in Production/ QA QC/ Engineering On 16th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 84

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 84

Pharma Pathway

SEPTEMBER 23, 2022

Hetero Labs Limited-Campus Interview for Freshers – Production/ QC / QA/ R&D / HR On 26th Sept’ 2022. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Pass out year: 2019 -2022 Pass outs. Job Description.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

SEPTEMBER 23, 2022

Hetero Labs Limited-Walk-In Interviews for AR&D/ FR&D On 24th Sept’ 2022. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

SEPTEMBER 12, 2022

-Walk-In Interviews for M.Sc / B.Sc/ B.Pharm/ B.Com/ ITI/ Diploma Freshers On 13th Sept’ 2022. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

MAY 17, 2023

billion in 2022. QMS are the integrated processes and procedures that ensure that pharmaceutical products are developed, manufactured and distributed in compliance with regulatory requirements and meet the desired quality standards. This helps pharma company’s sensitive data to be safe and secure.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Drug Development 98

Pharma Pathway

MARCH 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in QC -Instrumentation On 4th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 83

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 83

Pharma Pathway

FEBRUARY 20, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 21st Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

DECEMBER 14, 2022

On 15th & 16th Dec’ 2022. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Company Name: Dr. Reddy’s Laboratories.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

DECEMBER 19, 2022

is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Passout: 2021 to 2022 Batch. Reddy’s Laboratories Ltd.-Hiring Job Description.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

JANUARY 30, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC/ Production On 3rd Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 89

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 89

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 95

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 95

pharmaphorum

JUNE 23, 2025

Skip to main content Monday 23 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

European Pharmaceutical Review

APRIL 3, 2024

Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. percent between 2022-2030. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market. percent between 2022-2030.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Compounding 52

Pharma Pathway

FEBRUARY 27, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & experienced in Production/ Packing/ QC/ QA/ Stores On 4th March 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Officer/ Officer/ Operator/ Sr.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 17, 2025

billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023. billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

JUNE 25, 2025

Skip to main content Wednesday 25 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Express Pharma

OCTOBER 16, 2024

Bioeconomy is a critical growth multiplier of the Indian economy – according to the India BioEconomy Report 2022, BioEconomy accounts for nearly 2.6 Manufacturing costs in India are also 30 – 35 per cent lower than those in the US and Europe (5), further sweetening the deal for global pharmaceutical companies.

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Drug Development 52

Drug Development Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

pharmaphorum

JUNE 27, 2025

Skip to main content Friday 27 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Drug Development 52

Drug Development Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines 71

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies 71

Pharmaceutical Business Review

APRIL 9, 2023

MEDIBIYO is expected to begin operations to meet demands of the pharmaceutical companies. In 2022, the country’s first biosimilar drug project from cell to drug was undertaken via a partnership with the pharmaceutical industry under the supervision of TÜBITAK and MAM.

Vaccines 52

Vaccines Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 25, 2025

Biopharmaceutical companies developing Alzheimer’s disease innovator drugs have witnessed a flurry of acquisitions over the past few years, surging in total deal value by more than 780% from $2 billion in 2022 to almost $18 billion in 2024. The momentum in acquisition activity continued into 2025, with total deal value reaching $16.8

Packaging 59

Packaging Biosimilars Communication Hospitals 59